MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617039654 A) filed by The Board Of Regents Of The University Of Texas on March 30, 2026, for Endogenous Mitochondria Targeting Signal Peptides And Uses Thereof.
Inventors include Siegwart, Daniel J.; Farbiak, Lukas; and Miller, William.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: Provided for herein are novel recombinant polypeptides comprising endogenous mitochondria targeting signal peptides and a payload protein, nucleic acid molecules encoding the same, pharmaceutical compositions comprising the same, and methods of use thereof. In some embodiments, the recombinant polypeptide comprises a formula of X1-(Y l)a-Zl, wherein XI is an endogenous signal peptide, Y1 is a peptide linker, and Z1 is a payload protein, wherein a is an integer selected from 0 and 1.
Disclaimer: Curated by HT Syndication.
